Skip to main content

Table 2 Genotype and allele frequencies distribution of the IL-27 rs153109 polymorphism in the cases and controls of cohorts I and II

From: The interleukin-27 -964A>G polymorphism enhances sepsis-induced inflammatory responses and confers susceptibility to the development of sepsis

 

Cohort I + II

 

Cohort I

 

Cohort II

Cases

n (%)

Control n (%)

P

OR (95% CI)

Cases

n (%)

Controls n (%)

P OR (95% CI)

Cases

n (%)

Controls

n (%)

P OR (95% CI)

AA 334 (37.7)

417 (37.9)

0.885

233 (38.5)

276 (35.9)

0.605

101 (36.1)

141 (42.5)

0.183

AG 408 (46.1)

498 (45.2)

267 (44.1)

355 (46.2)

141 (50.3)

143 (43.1)

GG 143 (16.2)

186 (16.9)

105 (17.4)

138 (17.9)

38 (13.6)

48 (14.4)

AA/AG 742 (83.8)

915 (83.1)

0.661

1.06 (0.83–1.34)

500 (82.6)

631 (82.1)

0.776 1.04 (0.79–1.38)

242 (86.4)

284 (85.5)

0.753 1.08 (0.68–1.70)

AG/GG 551(62.3)

684 (62.1)

0.951

1.01 (0.84–1.21)

372 (61.5)

493 (64.1)

0.318 0.89 (0.72–1.11)

179 (63.9)

191 (57.5)

0.107 1.31 (0.94–1.81)

A 1076 (60.8)

1332 (60.5)

- 1.00 (reference)

733 (60.6)

907 (59.0)

- 1.00 (reference)

343 (61.3)

425 (64.0)

- 1.00 (reference)

G 694 (39.2)

870 (39.5)

0.847

0.99 (0.87–1.12)

477 (39.4)

631 (41.0)

0.394 0.94 (0.80–1.09)

217 (38.7)

239 (36.0)

0.320 1.13 (0.89–1.42)

  1. OR odds ratio, 95% CI 95% confidence interval